{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:55:52Z","timestamp":1792068952800,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,1,15]],"date-time":"2013-01-15T00:00:00Z","timestamp":1358208000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1038\/bjc.2012.560","type":"journal-article","created":{"date-parts":[[2013,1,15]],"date-time":"2013-01-15T21:11:16Z","timestamp":1358284276000},"page":"301-310","source":"Crossref","is-referenced-by-count":107,"title":["Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours"],"prefix":"10.1038","volume":"108","author":[{"name":"on behalf of the EORTC Quality of Life Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Yadegarfar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Friend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L M","family":"Plum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ardill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Taal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Jeziorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Kwekkeboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J K","family":"Ramage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,15]]},"reference":[{"issue":"3","key":"BFbjc2012560_CR1","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1677\/ERC-09-0042","volume":"16","author":"A Ahmed","year":"2009","unstructured":"Ahmed A, Turner G, King B, Jones L, Culliford D, McCance D, Ardill J, Johnston BT, Poston G, Rees M, Buxton-Thomas M, Caplin M, Ramage JK (2009) Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study. Endocr Relat Cancer 16 (3): 885\u2013894","journal-title":"Endocr Relat Cancer"},{"key":"BFbjc2012560_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3102\/10769986027004335","volume":"27","author":"DG Bonett","year":"2002","unstructured":"Bonett DG (2002) Sample size requirements for testing and estimating coefficient alpha. J Educ Behav Stat 27: 335\u2013340","journal-title":"J Educ Behav Stat"},{"issue":"3","key":"BFbjc2012560_CR3","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","volume":"11","author":"DF Cella","year":"1993","unstructured":"Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11 (3): 570\u2013579","journal-title":"J Clin Oncol"},{"issue":"2","key":"BFbjc2012560_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/BF02289113","volume":"16","author":"LJ Cronbach","year":"1951","unstructured":"Cronbach LJ, Warrington WG (1951) Time-limit tests: estimating their reliability and degree of speeding. Psychometrika 16 (2): 167\u2013188","journal-title":"Psychometrika"},{"key":"BFbjc2012560_CR5","unstructured":"Cull A, Sprangers M, Bjordal K, Aaronson N, West K, Bottomley A (2002) EORTC Quality of Life Group translation procedure Available at: \n                    http:\/\/groupseortcbe\/qol\/downloads\/200202translation_manualpdf"},{"issue":"4","key":"BFbjc2012560_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.ejca.2005.10.025","volume":"42","author":"AH Davies","year":"2006","unstructured":"Davies AH, Larsson G, Ardill J, Friend E, Jones L, Falconi M, Bettini R, Koller M, Sezer O, Fleissner C, Taal B, Blazeby JM, Ramage JK (2006) Development of a disease-specific Quality of Life Questionnaire module for patients with gastrointestinal neuroendocrine tumours. Eur J Cancer 42 (4): 477\u2013484","journal-title":"Eur J Cancer"},{"key":"BFbjc2012560_CR7","first-page":"A38","volume":"52","author":"AHG Davies","year":"2003","unstructured":"Davies AHG, Mason T, Stangou AJ al e (2003) Neuroendocrine tumours of the gut, liver and pancreas: overall survival in a large cohort. Gut 52: A38","journal-title":"Gut"},{"issue":"4","key":"BFbjc2012560_CR8","first-page":"637","volume":"137","author":"Z Davis","year":"1973","unstructured":"Davis Z, Moertel CG, McIlrath DC (1973) The malignant carcinoid syndrome. Surg Gynecol Obstet 137 (4): 637\u2013644","journal-title":"Surg Gynecol Obstet"},{"issue":"4","key":"BFbjc2012560_CR9","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/annonc\/mdl494","volume":"18","author":"F Efficace","year":"2007","unstructured":"Efficace F, Osoba D, Gotay C, Sprangers M, Coens C, Bottomley A (2007) Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making. Ann Oncol 18 (4): 775\u2013781","journal-title":"Ann Oncol"},{"issue":"12","key":"BFbjc2012560_CR10","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1038\/ajg.2010.341","volume":"105","author":"L Ellis","year":"2010","unstructured":"Ellis L, Shale MJ, Coleman MP (2010) Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971. Am J Gastroenterol 105 (12): 2563\u20132569","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"BFbjc2012560_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1081\/BIP-120028512","volume":"14","author":"PM Fayers","year":"2004","unstructured":"Fayers PM (2004) Quality-of-life measurement in clinical trials \u2013 the impact of causal variables. J Biopharm Stat 14 (1): 155\u2013176","journal-title":"J Biopharm Stat"},{"key":"BFbjc2012560_CR12","volume-title":"The EORTC QLQ-C30 Scoring Manual","author":"PM Fayers","year":"2001","unstructured":"Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A on behalf of the EORTC Quality of Life Group (2001) The EORTC QLQ-C30 Scoring Manual 3rd edn European Organisation for Research and Treatment of Cancer: Brussels"},{"key":"BFbjc2012560_CR13","volume-title":"User's Guide for the Multitrait Analysis Program (MAP)","author":"RD Hays","year":"1988","unstructured":"Hays RD, Havashi T, Carson S, Ware JE (1988) User's Guide for the Multitrait Analysis Program (MAP). Rand: Santa Monica, Canada"},{"issue":"3","key":"BFbjc2012560_CR14","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ijc.1473","volume":"94","author":"K Hemminki","year":"2001","unstructured":"Hemminki K, Li X (2001a) Familial carcinoid tumors and subsequent cancers: a nation-wide epidemiologic study from Sweden. Int J Cancer 94 (3): 444\u2013448","journal-title":"Int J Cancer"},{"issue":"8","key":"BFbjc2012560_CR15","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1002\/1097-0142(20011015)92:8<2204::AID-CNCR1564>3.0.CO;2-R","volume":"92","author":"K Hemminki","year":"2001","unstructured":"Hemminki K, Li X (2001b) Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden. Cancer 92 (8): 2204\u20132210","journal-title":"Cancer"},{"issue":"3","key":"BFbjc2012560_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1365-2796.1995.tb01175.x","volume":"237","author":"MB Jacobsen","year":"1995","unstructured":"Jacobsen MB, Hanssen LE (1995) Clinical effects of octreotide compared to placebo in patients with gastrointestinal neuroendocrine tumours. Report on a double-blind, randomized trial. J Intern Med 237 (3): 269\u2013275","journal-title":"J Intern Med"},{"issue":"7","key":"BFbjc2012560_CR17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1023\/A:1008215730767","volume":"8","author":"ET Janson","year":"1997","unstructured":"Janson ET, Holmberg L, Stridsberg M, Eriksson B, Theodorsson E, Wilander E, Oberg K (1997) Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center. Ann Oncol 8 (7): 685\u2013690","journal-title":"Ann Oncol"},{"issue":"9","key":"BFbjc2012560_CR18","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0959-8049(03)00236-3","volume":"39","author":"V Kavadas","year":"2003","unstructured":"Kavadas V, Blazeby JM, Conroy T, Sezer O, Holzner B, Koller M, Buckels J (2003) Development of an EORTC disease-specific Quality of Life Questionnaire for use in patients with liver metastases from colorectal cancer. Eur J Cancer 39 (9): 1259\u20131263","journal-title":"Eur J Cancer"},{"issue":"6","key":"BFbjc2012560_CR19","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1067\/msy.1998.93105","volume":"124","author":"PM Kirshbom","year":"1998","unstructured":"Kirshbom PM, Kherani AR, Onaitis MW, Feldman JM, Tyler DS (1998) Carcinoids of unknown origin: comparative analysis with foregut, midgut, and hindgut carcinoids. Surgery 124 (6): 1063\u20131070","journal-title":"Surgery"},{"issue":"1","key":"BFbjc2012560_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1046\/j.1365-2354.2003.00322.x","volume":"12","author":"G Larsson","year":"2003","unstructured":"Larsson G, Haglund K, Von Essen L (2003) Distress, quality of life and strategies to \u2018keep a good mood\u2019 in patients with carcinoid tumours: patient and staff perceptions. Eur J Cancer Care (Engl) 12 (1): 46\u201357","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"7","key":"BFbjc2012560_CR21","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1080\/02841860152703445","volume":"40","author":"G Larsson","year":"2001","unstructured":"Larsson G, Sjoden PO, Oberg K, Eriksson B, von Essen L (2001) Health-related quality of life, anxiety and depression in patients with midgut carcinoid tumours. Acta Oncol 40 (7): 825\u2013831","journal-title":"Acta Oncol"},{"issue":"11","key":"BFbjc2012560_CR22","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1023\/A:1008360718646","volume":"10","author":"G Larsson","year":"1999","unstructured":"Larsson G, Sjoden PO, Oberg K, von Essen L (1999a) Importance-satisfaction discrepancies are associated with health-related quality of life in five-year survivors of endocrine gastrointestinal tumours. Ann Oncol 10 (11): 1321\u20131327","journal-title":"Ann Oncol"},{"issue":"4","key":"BFbjc2012560_CR23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/028418699432022","volume":"38","author":"G Larsson","year":"1999","unstructured":"Larsson G, von Essen L, Sjoden PO (1999b) Health-related quality of life in patients with endocrine tumours of the gastrointestinal tract. Acta Oncol 38 (4): 481\u2013490","journal-title":"Acta Oncol"},{"issue":"4","key":"BFbjc2012560_CR24","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/cncr.11105","volume":"97","author":"IM Modlin","year":"2003","unstructured":"Modlin IM, Lye KD, Kidd M (2003) A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97 (4): 934\u2013959","journal-title":"Cancer"},{"issue":"1","key":"BFbjc2012560_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","volume":"9","author":"IM Modlin","year":"2008","unstructured":"Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A (2008) Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 9 (1): 61\u201372","journal-title":"Lancet Oncol"},{"issue":"4","key":"BFbjc2012560_CR26","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2","volume":"79","author":"IM Modlin","year":"1997","unstructured":"Modlin IM, Sandor A (1997) An analysis of 8305 cases of carcinoid tumors. Cancer 79 (4): 813\u2013829","journal-title":"Cancer"},{"issue":"2","key":"BFbjc2012560_CR27","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1067\/msy.2001.110426","volume":"129","author":"H Nave","year":"2001","unstructured":"Nave H, Mossinger E, Feist H, Lang H, Raab H (2001) Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years. Surgery 129 (2): 170\u2013175","journal-title":"Surgery"},{"key":"BFbjc2012560_CR28","volume-title":"Psychometric Theory","author":"J Nunnally","year":"1994","unstructured":"Nunnally J, Bernstein I (1994) Psychometric Theory 3rd edition ed McGraw-Hill: New York"},{"issue":"4","key":"BFbjc2012560_CR29","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<770::AID-CNCR6>3.0.CO;2-0","volume":"88","author":"D O\u2019Toole","year":"2000","unstructured":"O\u2019Toole D, Ducreux M, Bommelaer G, Wemeau JL, Bouche O, Catus F, Blumberg J, Ruszniewski P (2000) Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance. Cancer 88 (4): 770\u2013776","journal-title":"Cancer"},{"issue":"1","key":"BFbjc2012560_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/gutjnl-2011-300831","volume":"61","author":"JK Ramage","year":"2012","unstructured":"Ramage JK, Ahmed A, Ardill J, Bax N, Breen DJ, Caplin ME, Corrie P, Davar J, Davies AH, Lewington V, Meyer T, Newell-Price J, Poston G, Reed N, Rockall A, Steward W, Thakker RV, Toubanakis C, Valle J, Verbeke C, Grossman AB (2012) Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut 61 (1): 6\u201332","journal-title":"Gut"},{"issue":"4","key":"BFbjc2012560_CR31","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1677\/erc.0.0100483","volume":"10","author":"JK Ramage","year":"2003","unstructured":"Ramage JK, Davies AH (2003) Measurement of quality of life in carcinoid\/neuroendocrine tumours. Endocr Relat Cancer 10 (4): 483\u2013486","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"BFbjc2012560_CR32","first-page":"815","volume":"229","author":"KO Shebani","year":"1999","unstructured":"Shebani KO, Souba WW, Finkelstein DM, Stark PC, Elgadi KM, Tanabe KK, Ott MJ (1999) Prognosis and survival in patients with gastrointestinal tract carcinoid tumors. Endocr Relat Cancer 229 (6): 815\u2013821, discussion 822\u2013823","journal-title":"Endocr Relat Cancer"},{"key":"BFbjc2012560_CR33","unstructured":"Snow ND, Liddle RA (1995) Neuroendocrine tumors. In Gastrointestinal Cancers: Biology, Diagnosis and Therapy, Rustigi AK (ed), p 585., Lippincott-Raven: Philadelphia"},{"issue":"1","key":"BFbjc2012560_CR34","first-page":"3","volume":"17","author":"J Soga","year":"1998","unstructured":"Soga J (1998) Statistical evaluation of 2001 carcinoid cases with metastases, collected from literature: a comparative study between ordinary carcinoids and atypical varieties. J Exp Clin Cancer Res 17 (1): 3\u201312","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"BFbjc2012560_CR35","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s002680010236","volume":"24","author":"JA Soreide","year":"2000","unstructured":"Soreide JA, van Heerden JA, Thompson GB, Schleck C, Ilstrup DM, Churchward M (2000) Gastrointestinal carcinoid tumors: long-term prognosis for surgically treated patients. World J Surg 24 (11): 1431\u20131436","journal-title":"World J Surg"},{"key":"BFbjc2012560_CR36","volume-title":"Using Multivariate Statistics","author":"BJ Tabachnik","year":"1993","unstructured":"Tabachnik BJ, Fidel LS (1993) Using Multivariate Statistics. Harper and Row: London"},{"issue":"3","key":"BFbjc2012560_CR37","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1097\/MPA.0b013e31819b6441","volume":"38","author":"E Vinik","year":"2009","unstructured":"Vinik E, Carlton CA, Silva MP, Vinik AI (2009) Development of the Norfolk quality of life tool for assessing patients with neuroendocrine tumors. Pancreas 38 (3): e87\u2013e95","journal-title":"Pancreas"},{"key":"BFbjc2012560_CR38","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.0.CO;2-E","volume":"17","author":"SD Walter","year":"1988","unstructured":"Walter SD, Eliasziw M, Donner A (1988) Sample size and optimal designs for reliability studies. Stat Med 17: 101\u2013110","journal-title":"Stat Med"},{"issue":"7","key":"BFbjc2012560_CR39","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1007\/s002689900136","volume":"20","author":"B Wangberg","year":"1996","unstructured":"Wangberg B, Westberg G, Tylen U, Tisell L, Jansson S, Nilsson O, Johansson V, Schersten T, Ahlman H (1996) Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction. World J Surg 20 (7): 892\u2013899, discussion 899","journal-title":"World J Surg"},{"issue":"1","key":"BFbjc2012560_CR40","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/ije\/31.1.168","volume":"31","author":"NJ Wareham","year":"2002","unstructured":"Wareham NJ, Jakes RW, Rennie KL, Mitchell J, Hennings S, Day NE (2002) Validity and repeatability of the EPIC-Norfolk Physical Activity Questionnaire. Int J Epidemiol 31 (1): 168\u2013174","journal-title":"Int J Epidemiol"},{"issue":"Suppl 5","key":"BFbjc2012560_CR41","first-page":"95","volume":"57","author":"MH Wheeler","year":"2000","unstructured":"Wheeler MH, Maddox P, Maddineni S, Jordan S, Amer K, Butchart E (2000) Surgical treatment of carcinoid tumours. Przegl Lek 57 (Suppl 5): 95\u201397","journal-title":"Przegl Lek"},{"issue":"4","key":"BFbjc2012560_CR42","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1200\/JCO.1999.17.4.1111","volume":"17","author":"AN Wymenga","year":"1999","unstructured":"Wymenga AN, Eriksson B, Salmela PI, Jacobsen MB, Van Cutsem EJ, Fiasse RH, Valimaki MJ, Renstrup J, de Vries EG, Oberg KE (1999) Efficacy and safety of prolonged-release lanreotide in patients with gastrointestinal neuroendocrine tumors and hormone-related symptoms. J Clin Oncol 17 (4): 1111","journal-title":"J Clin Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2012560.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2012560","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2012560.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:12:23Z","timestamp":1684415543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2012560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,15]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["BFbjc2012560"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2012.560","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,15]]}}}